Astellas Pharma, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3942400007
JPY
2,048.00
28 (1.39%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
19,12,323.00
16,03,672.00
15,18,619.00
12,96,163.00
12,49,528.00
13,00,843.00
13,06,348.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
19,12,323.00
16,03,672.00
15,18,619.00
12,96,163.00
12,49,528.00
13,00,843.00
13,06,348.00
Raw Material Cost
4,85,968.00
3,91,305.00
3,26,789.00
2,81,292.00
2,69,826.00
2,97,903.00
3,27,262.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14,349.00
9,368.00
3,620.00
4,949.00
2,335.00
3,004.00
1,302.00
Selling and Distribution Expenses
8,43,032.00
7,40,110.00
6,30,272.00
5,48,840.00
5,04,316.00
4,99,295.00
4,90,263.00
Other Expenses
31,330.20
28,481.90
27,250.80
24,106.10
22,215.40
22,122.20
20,738.00
Total Expenditure (Excl Depreciation)
16,56,651.00
14,25,602.00
12,33,189.00
10,76,142.00
9,98,631.00
10,21,424.00
10,26,207.00
Operating Profit (PBDIT) excl Other Income
255672
178070
285430
220021
250897
279419
280141
Other Income
-19,270.00
-13,434.00
-5,009.00
33,275.00
1,187.00
-3,653.00
14,147.00
Operating Profit (PBDIT)
4,35,534.00
3,22,476.00
3,86,159.00
3,32,980.00
3,24,736.00
3,42,162.00
3,57,746.00
Interest
14,349.00
9,368.00
3,620.00
4,949.00
2,335.00
3,004.00
1,302.00
Exceptional Items
-1,90,558.00
-1,27,136.00
-1,45,700.00
-91,950.00
-1,04,903.00
-25,751.00
-44,018.00
Gross Profit (PBDT)
14,26,355.00
12,12,367.00
11,91,830.00
10,14,871.00
9,79,702.00
10,02,940.00
9,79,086.00
Depreciation
1,99,132.00
1,57,840.00
1,05,738.00
79,684.00
72,652.00
66,396.00
63,458.00
Profit Before Tax
31,496.00
28,134.00
1,31,101.00
1,56,397.00
1,44,846.00
2,47,010.00
2,48,967.00
Tax
-19,510.00
7,924.00
33,647.00
32,800.00
24,734.00
49,939.00
26,702.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
50,747.00
17,045.00
98,714.00
1,24,086.00
1,20,589.00
1,95,411.00
2,22,265.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
50,747.00
17,045.00
98,714.00
1,24,086.00
1,20,589.00
1,95,411.00
2,22,265.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
50,747.00
17,045.00
98,714.00
1,24,086.00
1,20,589.00
1,95,411.00
2,22,265.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
15,13,255.00
15,95,988.00
15,07,954.00
14,60,308.00
13,86,115.00
12,89,168.00
12,58,396.00
Earnings per share (EPS)
28.24
9.47
54.09
67.05
64.9
104.08
114.94
Diluted Earnings per share
28.24
9.47
54.09
67.05
64.9
104.08
114.94
Operating Profit Margin (Excl OI)
13.37%
11.1%
18.8%
16.97%
20.08%
21.48%
21.44%
Gross Profit Margin
12.06%
11.6%
15.6%
18.21%
17.41%
24.09%
23.92%
PAT Margin
2.65%
1.06%
6.5%
9.57%
9.65%
15.02%
17.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 19.25% vs 5.60% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 197.72% vs -82.73% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 35.39% vs -14.13% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 53.17% vs 158.78% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Astellas Pharma, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
19,12,323.00
45,81,551.00
-26,69,228.00
-58.26%
Other Operating Income
0.00
0.00
0.00
Total Operating income
19,12,323.00
45,81,551.00
-26,69,228.00
-58.26%
Raw Material Cost
4,85,968.00
21,26,363.00
-16,40,395.00
-77.15%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
14,349.00
1,86,976.00
-1,72,627.00
-92.33%
Selling and Distribution Expenses
8,43,032.00
11,04,732.00
-2,61,700.00
-23.69%
Other Expenses
31,330.20
54,325.00
-22,994.80
-42.33%
Total Expenditure (Excl Depreciation)
16,56,651.00
39,61,321.00
-23,04,670.00
-58.18%
Operating Profit (PBDIT) excl Other Income
2,55,672.00
620,230.00
-3,64,558.00
-58.78%
Other Income
-19,270.00
-41,244.00
21,974.00
53.28%
Operating Profit (PBDIT)
4,35,534.00
13,47,695.00
-9,12,161.00
-67.68%
Interest
14,349.00
1,86,976.00
-1,72,627.00
-92.33%
Exceptional Items
-1,90,558.00
-2,20,252.00
29,694.00
13.48%
Gross Profit (PBDT)
14,26,355.00
24,55,188.00
-10,28,833.00
-41.90%
Depreciation
1,99,132.00
7,61,396.00
-5,62,264.00
-73.85%
Profit Before Tax
31,496.00
1,79,070.00
-1,47,574.00
-82.41%
Tax
-19,510.00
66,941.00
-86,451.00
-129.15%
Provisions and contingencies
0
0
0.00
Profit After Tax
50,747.00
1,07,928.00
-57,181.00
-52.98%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
50,747.00
1,07,928.00
-57,181.00
-52.98%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
215.00
-215.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
50,747.00
1,08,143.00
-57,396.00
-53.07%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
15,13,255.00
69,35,084.00
-54,21,829.00
-78.18%
Earnings per share (EPS)
28.24
67.23
-38.99
-57.99%
Diluted Earnings per share
28.24
67.23
-38.99
-57.99%
Operating Profit Margin (Excl OI)
13.37%
13.70%
0.00
-0.33%
Gross Profit Margin
12.06%
20.53%
0.00
-8.47%
PAT Margin
2.65%
2.36%
0.00
0.29%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,91,232.30 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 19.25% vs 5.60% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 5,074.70 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 197.72% vs -82.73% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 45,480.40 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 35.39% vs -14.13% in Mar 2024

Annual - Interest
Interest 1,434.90 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 53.17% vs 158.78% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.37%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024